Spondylarthritis (Spinal Arthritis)

01/01/2013 - "2 cases of HLA-B27-positive seronegative spondylarthritides in pediatric age treated with adalimumab."
01/01/2011 - "We report the case of a 61-year-old Caucasian woman who was treated with adalimumab for spondylarthritis and developed injection site reactions after the sixth dose. "
01/01/2011 - "Spondylarthritis presenting with an allergic immediate systemic reaction to adalimumab in a woman: a case report."
07/01/2008 - "Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two."
01/01/2010 - "Mycobacterium chelonae infection under adalimumab therapy for spondylarthritis."

04/01/2009 - "This study is the first to show that infliximab is effective for reducing clinical and imaging evidence of disease activity in patients with MRI-determined early axial spondylarthritis."
03/01/2010 - "[Protocol for inducing infliximab tolerance in a patient with psoriatic spondylarthritis]."
10/01/2007 - "The case of a young male is described, affected by Crohn disease with reactive Spondylarthritis essay with Infliximab to the dose of 3 mg/kgs. "
01/01/2006 - "The aim of the present work is to compare drug survival and safety of infliximab, etanercept, and adalimumab (tumor necrosis factor [TNF] antagonists) in spondylarthritis (SpA) with those of rheumatoid arthritis (RA). "
07/01/2009 - "We collected 69 cases of TB in patients treated for rheumatoid arthritis (n = 40), spondylarthritides (n = 18), inflammatory colitis (n = 9), psoriasis (n = 1) and Behçet's disease (n = 1) with infliximab (n = 36), adalimumab (n = 28), and etanercept (n = 5). "

07/01/2005 - "[Current evaluation of efficacy of radon baths of various concentrations during rehabilitation of patients with seronegative spondylarthritis]."
07/01/2005 - "141 patients with seronegative spondylarthritis including ankylosing spondylarthritis (n = 90), reactive arthritis and Reiter's disease (n = 51) took water radon baths (concentration 1.5, 3.0 and 4.5 kB/l). "

10/01/2012 - "Inhibition of inflammation and destruction, but not of osteoproliferation, in patients with spondylarthritis (SpA) treated with anti-tumor necrosis factor raises the question of how these three processes are interrelated. "
06/01/2003 - "There is increasing evidence that tumor necrosis factor alpha (TNFalpha) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. "
02/01/2007 - "To study the relationship between inflammation and remodeling by inhibiting tumor necrosis factor alpha (TNFalpha) in male DBA/1 mice with spontaneous arthritis, a model of spondylarthritis (SpA). "
10/01/2010 - "To introduce a novel, simple, utility-based outcome measure, the number needed per quality-adjusted life year (QALY) gained (NNQ), and to apply it in clinical practice in anti-tumor necrosis factor (anti-TNF)-treated patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondylarthritis (SpA). "
12/01/2011 - "Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover."

06/01/2006 - "To identify biomarkers for effective treatment in early-phase clinical trials of spondylarthritis (SpA), by analyzing which synovial features can be reliably identified in patients with SpA. "
06/01/2006 - "Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis."
06/01/2006 - "Biomarkers in spondylarthritis: a peripheral vision."
06/01/2012 - "Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research]."
12/01/2011 - "Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover."

11/01/2002 - "We undertook this study to ascertain if patients with spondylarthritis express beta(2)-microglobulin-free HLA-B27 heavy chains in the form of homodimers and receptors for HLA-B27 homodimers. "
03/01/2013 - "Whether HLA-B27 misfolding facilitates the persistence of dormant bacteria within spondylarthritis tissue targets remains to be determined. "
10/01/2012 - "Expression of HLA-B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis."
08/01/2012 - "Male rats transgenic for HLA-B27 and human β(2) -microglobulin (hβ(2) m) spontaneously develop epididymoorchitis (EO) preceding the development of spondylarthritis (SpA). "
02/01/2010 - "The HLA-B27 allele is strongly associated with the group of inflammatory diseases known as the spondylarthritides (SpA). "

01/01/1979 - "With the investigation of HL A phenotypes of 133 patients with an akylozing spondylarthritis, 110 males and 23 females, confirmed incidence of antigen B 27 was established in 87.96 per cent versus 10.78 per cent of 1085 control healthy subjects. "
10/01/1976 - "HLA W27 antigen is present in the majority of the patients although spondylarthritis is not seen during the evolution. "
06/01/1976 - "[The lymphocyte transformation test with the bedsonian antigen (bedsonian LTT) in old and recent Fiessinger-Leroy-Reiter syndromes and in ankylsoing spondylarthritis. "
03/01/1987 - "In a family of four patients with ankylosing spondylarthritis, the study of HLA typing has permitted to establish the dissociated transmission of the B27 antigen and the spondylarthritis: as a matter of fact, if the father and his two sons have the disease, and carry the B27, one of the daughters is also definitely affected with spondylarthritis according to New York criteria, and does not carry the B27. "
01/01/2011 - "Moreover, our patient (human leucocyte antigen B27 positive) presented symptoms of spondylarthritis which also may have a nosological link with tuberculosis or sarcoidosis."

10/01/2011 - "Increasing the etanercept dose to 100 mg/week improves efficacy in cutaneous psoriasis, a clinical manifestation related to the spondylarthritis family, while maintaining its safety profile. "
09/01/2007 - "We report the development of thymic atypical carcinoid tumor 9 months after the initiation of etanercept therapy in a patient having refractory spondylarthritis. "
02/01/2013 - "The second was a 42-year-old man who received adalimumab and then etanercept for a peripheral spondylarthritis. "
02/01/2013 - "The first patient was a 53-year-old man who presented with an axial and peripheral spondylarthritis who was treated with etanercept and adalimumab. "
01/01/2014 - "The aim of this study was to investigate the influence of symptom duration on treatment response and on the correlation between improvements in patient reported outcomes (PRO) and objective inflammation in patients with axial spondylarthritis (SpA) treated with etanercept (ETA) or adalimumab (ADA). "

12/01/2013 - "This study aims to investigate any associations of the proinflammatory cytokine IL-1 in treated patients with inflammatory bowel disease (IBD) and the enteropathic seronegative spondylarthritis (eSpA). "
12/01/2013 - "Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis."
09/01/2006 - "The inflammatory cytokines tumor necrosis factor alpha (TNFalpha) and interleukin-1 (IL-1) are produced by activated macrophages, are key mediators of pathogenesis, and are validated therapeutic targets in rheumatoid arthritis (RA) and seronegative spondylarthritis (SpA). "

01/01/1979 - "Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study."

11/01/1957 - "[Efficacy of ultrasonic therapy in comparison with other physical therapeutic methods in painful complications of spondylarthritis]."

07/01/2005 - "The baths proved similarly effective in patients with seronegative spondylarthritis. "
07/01/2005 - "[Current evaluation of efficacy of radon baths of various concentrations during rehabilitation of patients with seronegative spondylarthritis]."
07/01/2005 - "141 patients with seronegative spondylarthritis including ankylosing spondylarthritis (n = 90), reactive arthritis and Reiter's disease (n = 51) took water radon baths (concentration 1.5, 3.0 and 4.5 kB/l). "

11/06/2007 - "Our studies on invasive cane toads in Australia reveal severe spinal arthritis in approximately 10% of large adult toads, associated with the same factors (large body size, frequent movement, and relatively long legs) that have enabled toads to invade so rapidly across the Australian tropics."
11/06/2007 - "Invasion, stress, and spinal arthritis in cane toads."

01/01/1996 - "Osteotomy was performed at L3 in all cases of spondylarthritis with a mean 30 degrees correction (24-37 degrees) which was maintained after 5 to 18 months follow-up (mean 10 months). "
12/07/1980 - "[Osteotomy of the lumbar spine in ankylopoietic spondylarthritis]."

01/01/2000 - "In all, 47 thrust plate prostheses were implanted in 42 patients with polyarthritis (29 with rheumatoid arthritis, 6 with juvenile chronic arthritis, and 7 with spondylarthritis) and followed prospectively. "